First Quadrant’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-6,222
| Closed | -$2.88M | – | 263 |
|
|
2021
Q4 | $2.88M | Hold |
6,222
| – | – | 0.31% | 63 |
|
|
2021
Q3 | $2.32M | Hold |
6,222
| – | – | 0.27% | 80 |
|
|
2021
Q2 | $2.38M | Hold |
6,222
| – | – | 0.27% | 79 |
|
|
2021
Q1 | $2.23M | Hold |
6,222
| – | – | 0.24% | 90 |
|
|
2020
Q4 | $2M | Sell |
6,222
-1,253
| -17% | -$385K | 0.2% | 94 |
|
|
2020
Q3 | $2.01M | Sell |
7,475
-525
| -7% | -$141K | 0.26% | 80 |
|
|
2020
Q2 | $2.1M | Buy |
8,000
+1,947
| +32% | +$519K | 0.28% | 89 |
|
|
2020
Q1 | $1.37M | Hold |
6,053
| – | – | 0.2% | 130 |
|
|
2019
Q4 | $1.83M | Hold |
6,053
| – | – | 0.15% | 132 |
|
|
2019
Q3 | $1.45M | Sell |
6,053
-13,704
| -69% | -$3.75M | 0.14% | 162 |
|
|
2019
Q2 | $5.58M | Sell |
19,757
-1,557
| -7% | -$425K | 0.39% | 52 |
|
|
2019
Q1 | $6.12M | Sell |
21,314
-118
| -0.6% | -$34.1K | 0.47% | 43 |
|
|
2018
Q4 | $5.63M | Hold |
21,432
| – | – | 0.45% | 42 |
|
|
2018
Q3 | $5.87M | Sell |
21,432
-16,518
| -44% | -$4.29M | 0.13% | 195 |
|
|
2018
Q2 | $9.03M | Hold |
37,950
| – | – | 0.17% | 176 |
|
|
2018
Q1 | $8.34M | Sell |
37,950
-127,920
| -77% | -$30M | 0.16% | 184 |
|
|
2017
Q4 | $37.3M | Buy |
165,870
+94,224
| +132% | +$20.1M | 0.7% | 15 |
|
|
2017
Q3 | $13.6M | Sell |
71,646
-20,139
| -22% | -$3.83M | 0.26% | 136 |
|
|
2017
Q2 | $17.3M | Buy |
91,785
+70,063
| +323% | +$12.6M | 0.35% | 102 |
|
|
2017
Q1 | $3.59M | Hold |
21,722
| – | – | 0.07% | 278 |
|
|
2016
Q4 | $3.12M | Hold |
21,722
| – | – | 0.06% | 286 |
|
|
2016
Q3 | $2.72M | Hold |
21,722
| – | – | 0.06% | 296 |
|
|
2016
Q2 | $2.85M | Hold |
21,722
| – | – | 0.06% | 247 |
|
|
2016
Q1 | $3.02M | Sell |
21,722
-600
| -3% | -$80.2K | 0.07% | 249 |
|
|
2015
Q4 | $3.11M | Sell |
22,322
-861
| -4% | -$119K | 0.07% | 263 |
|
|
2015
Q3 | $3.25M | Hold |
23,183
| – | – | 0.07% | 249 |
|
|
2015
Q2 | $3.81M | Hold |
23,183
| – | – | 0.08% | 224 |
|
|
2015
Q1 | $3.58M | Sell |
23,183
-242,567
| -91% | -$34.5M | 0.07% | 212 |
|
|
2014
Q4 | $33.4M | Sell |
265,750
-17,572
| -6% | -$2.17M | 0.7% | 37 |
|
|
2014
Q3 | $33.9M | Buy |
283,322
+3,600
| +1% | +$413K | 0.76% | 34 |
|
|
2014
Q2 | $30.1M | Buy |
279,722
+257,600
| +1,164% | +$26.5M | 0.67% | 38 |
|
|
2014
Q1 | $2.2M | Sell |
22,122
-1,000
| -4% | -$90.4K | 0.05% | 296 |
|
|
2013
Q4 | $2.14M | Hold |
23,122
| – | – | 0.05% | 310 |
|
|
2013
Q3 | $1.93M | Sell |
23,122
-13,100
| -36% | -$1.12M | 0.05% | 299 |
|
|
2013
Q2 | $2.96M | Buy |
+36,222
| New | +$2.71M | 0.08% | 250 |
|
Other funds holding ELV
First Quadrant's ELV Position: Q1 2022 in Review
First Quadrant sold out of Elevance Health (ELV) in Q1 2022, closing a stake of 6,222 shares — an estimated $2.88M sold.
First Quadrant first reported a position in ELV in Q2 2013 and held it in 35 quarters. The position peaked at $37.3M in Q4 2017. 1,419 funds tracked by Wall St. Rank hold ELV as of Q1 2022.
- First Quadrant reported no remaining Elevance Health position as of Q1 2022 after selling out during the quarter.
- First Quadrant sold 6,222 Elevance Health shares in Q1 2022, an estimated $2.88M.
- First Quadrant first reported a position in Elevance Health in Q2 2013 and held it in 35 quarters.
- First Quadrant's Elevance Health position peaked at $37.3M in Q4 2017.
- 1,419 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.
Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.